Showing results (311-320 of 2,991) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosisC A McNamara, I J Sarembock, B G Bachhuber, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin-mediated events implicated in mast cell activationS M Strukova, T N Dugina, S V Khlgatian, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Effect of defibrotide on platelet functionO N Ulutin, S Balkuv-Ulutin, B Bezer-Göker, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Clinical trials with defibrotide in vascular disordersC CimminielloSeminars in Thrombosis and Hemostasis|January 1, 1996
Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosisJ Amiral, J FareedSeminars in Thrombosis and Hemostasis|January 1, 1995
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparinsW Jeske, J C Lormeau, D Callas, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiationW Jeske, O Iqbal, S Gonnela, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week periodB Lojewski, P Bacher, O Iqbal, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
The Thrombostat system. A useful method to test antiplatelet drugs and dietsM A Kratzer, E V Negrescu, A Hirai, et al.Pageof 300